Immunohistochemical expression of metallothionein in invasive breast cancer in relation to proliferative activity, histology and prognosis

Oncology (Switzerland)

Volumn 53, Issue 2, 1996, Pages 112-117

  Oyama, Tetsunari ^a   Takei, Hiroyuki ^b   Hikino, Toshiaki ^a   Iino, Yuichi ^b   Nakajima, Takashi ^a  

^a Gunma University   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Breast cancer; Cell proliferation; Immunohistochemistry; Metallothionein

Indexed keywords

ESTROGEN RECEPTOR; METALLOTHIONEIN;

ADULT; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER INVASION; CELL NUCLEUS; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MENOPAUSE; ONCOGENE C ERB; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SPINDLE CELL; SURVIVAL RATE; TUMOR VOLUME;

ADULT; BREAST NEOPLASMS; CARCINOMA; CELL DIVISION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; METALLOTHIONEIN; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL RATE;

EID: 0029963964     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000227546     Document Type: Article

References (22)

1. Hamer DE: Mctallothionein. Annu Rev Bio-chem 1986:55:913-951.
2. Panemangalore M, Bancrjcc D, Onosaka S. et al: Changes in the intracellular accumulation and distribution of mcthallothionein in rat liver and kidney during postnatal development. Dev Biol 1983:97:95-102.
3. Nii Nartey M, Cherian G, Banerjce D: Intmu-nohistochcmical localization of metallothio-ncin in human thyroid tumors. Am J Pathol 1987;129:177-182.
4. Kontozoglou TE, Banerjee D, Cherian MG: Immunohistochemical localization of mctallothionein in human testicular embryonal carcinoma cells. Virchows Arch A 1989:415:545-549.
5. Nishimura H, Nishimura N, Tohyama C: Localization of mctallothionein in the genital organs of male rat. J Histochem Cytochem 1990: 38:927-933.
6. Suzuki K, Nakjima K, Otaki N, et al: Localization of metallothioncin in aged human brain. Pathol Int 1994:44:20-26.
7. Schmid KW, Ellis IO, Gee NW. et al: Presence anc possible significance of immunocytochem-icallv demonstrable mctallothionein over-expression in primary invasive ductal carcinoma. Virchow Arch A 1993:422:153-159.
8. Fresno M, Wu W, Rodriguez JM. el al: Localization of mctallothionein in breast carcinomas. An immunohistochemical study. Virchows Arch A 1993:423:215-219.
9. Douglas-Jones AG, Frcpa KW, Schmid KW. et al: Metallothioncin expression in duct carcinoma in situ of the breast. Hum Pathol 1995:26: 217-222.
10. Hartmann WH, Ozzcllo L, Sobin LH. et al: Histological typing of breast tumors, ed 2: in WHO (cd): International Histological Classification ofTumors. Geneva, WHO, 1981.
11. Japanese Breast Cancer Society: General Rules for Clinical and Pathological Recording of Breast Cancer, ed 10. Tokyo. Kinbara, 1989.
12. Bloom HJG, Richardson WW: Histological grade and prognosis in breast cancer. Br J Cancer 1957; 11:359-377.
13. Andrews GK, Adamson ED, Gedamu L: The ontogeny of expression of murine metallo-thionein: Comparison with the a-fetoprotcin gene. Dev Biol 1984:103:294-303.
14. Kelley SL, Basu A, Teicher BA. et al: Overexpression of metallothionein confers resistance to anticancer drugs. Science 1988:241:1813-1815.
15. Webber MM, Rehman SMM, James GT: Metallothionein induction and deinduction in human prostatic carcinoma cells: Relationship with resistance and sensitivity to adriamycin. Cancer Res 1988:48:4503-4508.
16. Murphy D, McGrown AT, Crowthcr D. ct al: Metallothionein levels in ovarian tumors before and after chemotherapy. Br J Cancer 1991; 63:711-714.
17. Chin JL, Bancrjec D, Kadhim SA, et al: Metallothionein in testicular germ cell tumors and drug resistance. Cancer 1993:72:3029-3035.
18. Satoh M, Kloth DM, Kadhim SA, et al: Modulation ofboth cisplatin nephrotoxicity and drug resistance in murine bladder tumor by controlling metallothionein synthesis. Cancer Res 1993;53:1829-1832.
19. Gerdes J, Lemke H, Baisch H, et al: Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133:1710-1715.
20. Weidner N, Moore DH, Vartanian R: Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel ‘paraffin'-reactive M1B 1 antibedy. Hum Pathol 1994;25:337-342.
21. Tsujikawa K, Sagawa K, Suzuki N. et al: The relationship between nuclear localization of metallothioncin and proliferation of rat hepa-tocytes: in Suzuki KT. Imura N. Kimura M (eds): Metallothioncin 111. Basel. Birkhäuscr Verlag. 1993. pp 427-442.
22. Chcrian MG: Nuclear and cytoplasmic localization of metallothionein in human liver during development and in tumor cells; in Suzuki KT, Imura N. Kimura M (eds): Metallothionein III. Basel. Birkhäuser Verlag. 1993. pp 175-187.